Results 211 to 220 of about 403,170 (356)
Abstract Objective Up to 14% of women with early‐stage endometrial carcinoma (EEC) are diagnosed before menopause. Although ovarian preservation (OP) within surgical staging might avoid surgical menopause, its rate remains low in clinical practice, probably because the impact of OP on survival outcomes is unclear.
Antonio Raffone +12 more
wiley +1 more source
Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study. [PDF]
De Cicco Nardone C +7 more
europepmc +1 more source
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park +5 more
wiley +1 more source
Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case-control study. [PDF]
Gao L, Ju Y, Zhu Y, Xu J, Lu D.
europepmc +1 more source
The role of folic acid in prevention of neural tube defects caused by high dose progesterone. [PDF]
Iram Iqbal +4 more
openalex +1 more source
Abstract Objective To investigate the association between serum markers and successful conservative management of patients with placenta accreta spectrum (PAS). Methods This was a retrospective case–control study where patients with high‐grade PAS between 2011 and 2025 undergoing conservative leaving the placenta in situ were included.
Ammar Al Naimi +7 more
wiley +1 more source
Maternal brain alterations based on neurotransmitter and hormone receptor distributions over six months postpartum. [PDF]
Losse EM +4 more
europepmc +1 more source
Review of: Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity [PDF]
Carol A. Lange
openalex +1 more source
Clinical phases and classification of breast tumor dormancy. Tumor dormancy is described as the period after treatment until residual tumor cells become detectable as relapsing disease in clinic. During the period of clinical tumor dormancy, tumor mass dormancy and cellular dormancy may coexist.
Shu Chen +4 more
wiley +1 more source

